These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 12427357)
21. Postural changes, dysphagia, and systemic sclerosis. Barrera P; den Broeder AA; van den Hoogen FH; van Engelen BG; van de Putte LB Ann Rheum Dis; 1998 Jun; 57(6):331-8. PubMed ID: 9771206 [No Abstract] [Full Text] [Related]
22. The role of DMARDs in systemic sclerosis therapy. Blank N; Max R; Lorenz HM Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii42-4. PubMed ID: 16987834 [TBL] [Abstract][Full Text] [Related]
23. Intestinal pseudo-obstruction as an initial presentation of systemic sclerosis in two children. Ortiz-Alvarez O; Cabral D; Prendiville JS; Stringer D; Petty RE; Malleson PN Br J Rheumatol; 1997 Feb; 36(2):280-4. PubMed ID: 9133948 [TBL] [Abstract][Full Text] [Related]
24. Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases. Tio H; van Wijk L; de Haan E Acta Med Scand; 1973 May; 193(5):477-80. PubMed ID: 4717327 [No Abstract] [Full Text] [Related]
25. Keloidal scleroderma. Santiago M; de Castro DO; Costa CA; Passos ES; Paixão A Clin Rheumatol; 2004 Feb; 23(1):50-1. PubMed ID: 14749984 [TBL] [Abstract][Full Text] [Related]
26. Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis. Lin AT; Clements PJ; Furst DE Rheum Dis Clin North Am; 2003 May; 29(2):409-26. PubMed ID: 12841302 [TBL] [Abstract][Full Text] [Related]
28. Progressive systemic sclerosis and penicillamine. Rodnan GP J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873 [TBL] [Abstract][Full Text] [Related]
29. D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma). Medsger TA Arthritis Rheum; 1987 Jul; 30(7):832-4. PubMed ID: 3304300 [No Abstract] [Full Text] [Related]
30. Treatment of systemic sclerosis. Steen VD Am J Clin Dermatol; 2001; 2(5):315-25. PubMed ID: 11721650 [TBL] [Abstract][Full Text] [Related]
31. Disease modification and other trials in systemic sclerosis have come a long way, but have to go further. Pope JE; Khanna D; Johnson SR; Clements P Arthritis Care Res (Hoboken); 2012 Jul; 64(7):955-9. PubMed ID: 22422634 [No Abstract] [Full Text] [Related]
32. Successful treatment of far-advanced progressive systemic sclerosis by D-penicillamine. Kang B; Veres-Thorner C; Heredia R; Cha E; Bose S; Schwartz M J Allergy Clin Immunol; 1982 Mar; 69(3):297-305. PubMed ID: 7061771 [TBL] [Abstract][Full Text] [Related]
33. Methotrexate has no antifibrotic effect in bleomycin-induced experimental scleroderma. Ozgen M; Koca SS; Isik A; Ozercan IH J Rheumatol; 2010 Mar; 37(3):678-9. PubMed ID: 20197571 [No Abstract] [Full Text] [Related]
34. Bronchiolitis obliterans in a patient with localized scleroderma treated with D-penicillamine. Boehler A; Vogt P; Speich R; Weder W; Russi EW Eur Respir J; 1996 Jun; 9(6):1317-9. PubMed ID: 8804954 [TBL] [Abstract][Full Text] [Related]
35. Treatment Algorithms for Systemic Sclerosis According to Experts. Fernández-Codina A; Walker KM; Pope JE; Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586 [TBL] [Abstract][Full Text] [Related]